Micro Emerging Active

BMY Camzyos Uji coba Fase 3 berhasil

New narrative with limited coverage — still forming.

Skor
0,4
Kecepatan
▲ 1,0
Artikel
2
Sumber
2

Sentiment Timeline

Event Timeline

Apr 09, 2026
Oxford BioTherapeutics Partners Bristol Myers Squibb On T-Cell Engager Therapies For Solid … Bullish
Apr 02, 2026
Bristol-Myers Squibb (BMY) Announces Positive Data from the Phase 3 SCOUT-HCM Trial … Neutral

Lini Waktu

Pertama TerlihatApr 02, 2026
Terakhir DiperbaruiApr 02, 2026